U.S. close to deal to bankroll Moderna's bird flu vaccine trial, FT reports-March 2024-www.financetom.com

U.S. close to deal to bankroll Moderna's bird flu vaccine trial, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

U.S. close to deal to bankroll Moderna's bird flu vaccine trial, FT reports

May 29, 2024 9:25 PM

May 30 (Reuters) - The U.S. government is nearing an

agreement to fund a late-stage trial of Moderna's ( MRNA ) mRNA

pandemic bird flu vaccine, with a decision coming as early as

next month, the Financial Times reported on Thursday.

Previous page： Chile's SQM says it plans to pass mining concessions to Codelco in new partnership Next page： Lucero Energy Fourth-Quarter Profit Drops 11% on Lower Prices and Production

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Chile's SQM says it plans to pass mining concessions to Codelco in new partnership

Mar 21, 2024

SANTIAGO, March 21 (Reuters) - Chilean lithium miner SQM plans to transfer to state-run copper producer Codelco its mining concessions and other rights in Chile's Maricunga salt flat, the company said in a statement on Thursday. SQM said it discussed plans for the partnership with Codelco, which is still being negotiated, in a shareholders meeting earlier in the day. ...

Lucero Energy Fourth-Quarter Profit Drops 11% on Lower Prices and Production

Mar 21, 2024

04:45 PM EDT, 03/21/2024 (MT Newswires) -- Lucero Energy ( PSHIF ) on Thursday said its fourth-quarter profit fell 11% on lower oil and gas production and weaker prices. The North Dakota oil and gas producer said it earned C$16.88 million, or C$0.03 per share, in the period, down from C$19.0 million, or C$0.03, in the year-prior quarter. Revenue fell...

Nike Nike Fiscal Q3 Earnings Decline, Revenue Rises

Mar 21, 2024

04:46 PM EDT, 03/21/2024 (MT Newswires) -- Nike ( NKE ) reported fiscal Q3 earnings late Thursday of $0.77 per diluted share, down from $0.79 a year earlier. Analysts polled by Capital IQ forecast $0.71. Revenue for the quarter ended Feb. 29 was $12.43 billion, up from $12.39 billion a year earlier. Analysts surveyed by Capital IQ projected $12.30 billion....

Nike beats quarterly revenue estimates as newer styles draw customers

Mar 21, 2024

March 21 (Reuters) - Nike ( NKE ) beat Wall Street estimates for third-quarter revenue on Thursday, on the back of its newer sneaker styles that were launched to draw back customers amid rising competition from brands such as On and Decker's Hoka. Shares of the world's largest sportswear maker, which had fallen 7.2% in 2023, were up nearly 1%...